Millions of people worldwide struggle with debilitating inflammatory diseases. Existing biologic treatments often come with significant side effects and can be incredibly costly, limiting access for many patients.
Millions of people worldwide struggle with debilitating inflammatory diseases. Existing biologic treatments often come with significant side effects and can be incredibly costly, limiting access for many patients.
Rādyx is pioneering a new approach to drug development. Unlike traditional single-molecule drugs, our polymolecular formulations target multiple mechanisms involved in complex diseases. Inspired by nature's wisdom, our polymolecular drugs offer a safer, more comprehensive solution to chronic conditions by addressing both symptoms and underlying causes.
Botanical medicine and product development leader with 30 years of experience.
Former FDA and Pfizer-Warner Lambert development leader.
Quality and regulatory leader in botanical manufacturing.
Clinical and medical development leader in complex therapeutics.
Finance executive and angel investor with multiple company exits.
Co-founder and botanical formulation developer with 30 years of experience.
Investor relations, diligence, and angel network strategist.